ALUR |
ALLURION TECHNOLOGIES, INC. |
Common Stock, $0.0001 par value per share |
34.1% |
$6.18M |
$3.63M |
2.54M |
+142% |
RTW Investments, LP |
Apr 15, 2025 |
ALUR |
ALLURION TECHNOLOGIES, INC. |
Common Stock, $0.0001 par value per share |
17.6% |
$452K |
|
1.05M |
0% |
RTW Investments, LP |
Feb 20, 2025 |
OBIO |
ORCHESTRA BIOMED HOLDINGS, INC. |
Common Stock, par value $0.0001 per share |
15.4% |
$22M |
|
8.31M |
0% |
RTW Investments, LP |
Aug 4, 2025 |
ESTA |
Establishment Labs Holdings Inc. |
Common Shares, No Par Value |
9.99% |
$97.4M |
|
2.82M |
|
RTW Investments, LP |
Dec 31, 2024 |
STOK |
Stoke Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.99% |
$37.3M |
|
5.31M |
|
RTW Investments, LP |
Dec 31, 2024 |
NGNE |
Neurogene Inc. |
Common Stock, par value $0.000001 per share |
9.99% |
$16.5M |
|
1.5M |
|
RTW Investments, LP |
Dec 31, 2024 |
MIST |
Milestone Pharmaceuticals Inc. |
Common Shares, no par value per share |
9.99% |
$4.34M |
|
5.64M |
|
RTW Investments, LP |
Dec 31, 2024 |
TENX |
Tenax Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
9.99% |
$2.33M |
|
418K |
|
RTW Investments, LP |
Mar 31, 2025 |
SABS |
SAB Biotherapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.99% |
$1.31M |
|
1.02M |
|
RTW Investments, LP |
Dec 31, 2024 |
TSHA |
TAYSHA GENE THERAPIES, INC. |
Common Stock, par value $0.00001 per share |
9.9% |
$75.5M |
$13.5M |
25.2M |
+21.8% |
RTW Investments, LP |
Jun 30, 2025 |
VSTM |
Verastem, Inc. |
Common Stock, $0.0001 par value |
9.9% |
$51.1M |
$12.5M |
5.63M |
+32.5% |
RTW Investments, LP |
Jun 30, 2025 |
CMPS |
COMPASS Pathways plc |
Ordinary Shares, par value GBP 0.008 per share |
9.9% |
$45.6M |
$7.68M |
9.47M |
+20.3% |
RTW Investments, LP |
Jun 30, 2025 |
QURE |
uniQure N.V. |
Ordinary Shares, par value 0.05 euro |
9.4% |
$81.4M |
$14.1M |
5.16M |
+20.9% |
RTW Investments, LP |
Jun 30, 2025 |
GHRS |
GH Research PLC |
Ordinary shares, nominal value $0.025 per share |
8.9% |
$49.5M |
|
5.5M |
|
RTW Investments, LP |
Mar 31, 2025 |
RAPT |
Rapt Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
8.9% |
$10M |
|
11.8M |
|
RTW Investments, LP |
Mar 31, 2025 |
TARS |
Tarsus Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
8.1% |
$184M |
|
3.42M |
|
RTW Investments, LP |
Jun 30, 2025 |
XGN |
Exagen Inc. |
Common Stock, par value $0.001 per share |
7.7% |
$16.7M |
|
1.7M |
|
RTW Investments, LP |
Jun 30, 2025 |
BBNX |
Beta Bionics, Inc. |
Common Stock, $0.0001 par value per share |
7.6% |
$39M |
|
3.3M |
|
RTW Investments, LP |
Mar 31, 2025 |
AKRO |
Akero Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
7.3% |
$287M |
-$48.2M |
5.87M |
-14.4% |
RTW Investments, LP |
Jun 30, 2025 |
CRGX |
CARGO THERAPEUTICS, INC. |
Common stock, par value $0.001 per share |
6.4% |
$13.7M |
|
3.06M |
|
RTW Investments, LP |
Jun 30, 2025 |
SYRE |
Spyre Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
6.2% |
$44.3M |
|
3.62M |
|
RTW Investments, LP |
Dec 31, 2024 |
APGE |
Apogee Therapeutics, Inc. |
Common Stock, $0.00001 par value per share |
6% |
$86.2M |
|
2.71M |
|
RTW Investments, LP |
Dec 31, 2024 |
IMTX |
Immatics N.V. |
Ordinary Shares, nominal value EURO 0.01 per share |
5.5% |
$27.1M |
|
6.54M |
|
RTW Investments, LP |
Dec 31, 2024 |
ACAD |
Acadia Pharmaceuticals Inc. |
Common Stock, par value $0.0001 per share |
5.2% |
$123M |
|
8.71M |
|
RTW Investments, LP |
Dec 31, 2024 |
ORKA |
Oruka Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
5.2% |
$18.3M |
|
1.95M |
|
RTW Investments, LP |
Mar 31, 2025 |
ZLAB |
Zai Lab Limited |
Ordinary Shares, par value $0.000006 per share |
5.1% |
$1.78B |
|
55.4M |
|
RTW Investments, LP |
Jun 30, 2025 |
SAGE |
Sage Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
4.9% |
$20.7M |
|
3M |
|
RTW Investments, LP |
Dec 31, 2024 |
AXSM |
Axsome Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
3.1% |
$177M |
-$164M |
1.52M |
-48.1% |
RTW Investments, LP |
Jun 30, 2025 |
EPIX |
ESSA Pharma Inc. |
Common Shares, no par value |
2.5% |
$1.69M |
|
1.11M |
|
RTW Investments, LP |
Dec 31, 2024 |
DYN |
Dyne Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
1.5% |
$12.8M |
-$26.6M |
1.69M |
-67.6% |
RTW Investments, LP |
Mar 31, 2025 |
ETNB |
89bio, Inc. |
Common Stock, par value $0.001 per share |
1.3% |
$14.3M |
|
1.97M |
|
RTW Investments, LP |
Mar 31, 2025 |
IMUX |
Immunic, Inc. |
Common Stock, par value $0.0001 per share |
1.1% |
$924K |
|
1.03M |
|
RTW Investments, LP |
Mar 31, 2025 |
CUTRQ |
Cutera, Inc. |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
RTW Investments, LP |
Dec 31, 2024 |
PEPG |
PepGen Inc. |
Common Stock, $0.0001 par value per share |
0% |
$0 |
-$3.61M |
0 |
-100% |
RTW Investments, LP |
Mar 31, 2025 |
GERN |
Geron Corporation |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
RTW Investments, LP |
Dec 31, 2024 |